MedXtractor Corp.

publicPublic Group

MedXtractor manufactures patented, small-scale CO2-based cannabis oil extractors for sale worldwide We focus on hundreds-of-thousands of Craft-style growers who produce small-batch, very-high-quality cannabis products.

people23 Members       (0)

Corporate Profile
Group Admins:
  • Thumb d arcy pif photo 002
  • Thumb 8020 monitor 200200 2
  • Thumb 8020 media relations
  • Thumb no photo
Add Corporate Feed


MedXtractor Corp.

publicPublicGroup

MedXtractor manufactures patented, small-scale CO2-based cannabis oil extractors for sale worldwide We focus on hundr......

people23 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

5 hours ago

8020 Admin posted a press release MedXtractor Corp. Reports Increased Co2 Extractor Sales in MEDXTRACTOR CORP.

Calgary, Alberta--(Newsfile Corp. - December 4, 2019) - MedXtractor Corp. (CSE: MXT) ("MXT" or the "Corporation") announces an strong increase in extractor unit sales.


Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6610/50322_24075386948c59c0_002full.jpg


Figure 1


To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6610/50322_24075386948c59c0_002full.jpg


Mr. Jim Durward, CEO, states "While our unit sales have been trending upward over the past year, we believe that the Q3, 2020 jump is primarily due to seasonal harvest demand and that the trend may normalize in Q4. This said, the combination of US-Federal Hemp/CBD legalization, medical demand for extract purity due to the vape diluent issue and general demand for small-scale CO2-based extractors from the craft medical horizontal, is expected to support increasing organic growth going forward. With greater than 70% of sales now originating internationally, our growth prospects are worldwide and independent of the Canadian market. We focus on the craft medical horizontal, a generally overlooked market sector that we believe consists of a much larger number of potential customers than the far narrower corporate grower/extractor sector. For example, Health Canada reports that there were greater than 28,000 personal production licenses (June, 2019) vs. less than 300 large Licensed Producers. These craft growers are also not restricted as to the potency of their extracts and can use full-strength extracts without the addition of any diluents. MXT is uniquely positioned to support this horizontal with its affordable, small-scale CO2 extractors designed specifically for craft growers. While the capital markets have recently tightened for cannabis-related companies, our tight expense control means we don't require financing to execute our current business plan. I believe that our organic growth, combined with one of the lowest market capitalizations of any public cannabis-related company, makes MXT an excellent addition to any cannabis-related portfolio."


ABOUT MEDXTRACTOR CORP.:


The Corporation is a Calgary-based company that manufactures patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft medical cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the US patent, and the Canadian Patent application, on its CO2-based extraction process.


FOR FURTHER INFORMATION, PLEASE CONTACT:


MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com
Website: www.medxtractor.com


This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.


The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50322

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release CSE New Listing - MEDXtractor Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com in MEDXTRACTOR CORP.

Vancouver, British Columbia--(Newsfile Corp. - October 25, 2019) -  MEDXtractor Corp. (CSE:MXT) is one of the latest new listings on the Canadian Securities Exchange. The Calgary-based company manufactures patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials.




Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_ioncbvux/New-Listing-MEDXtractor-Corp-CSEMXT-


For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "MEDXtractor" in the search box.


The company specifically targets the "Craft" cannabis grower. Craft growers are those whose crop is up to 800 indoor-sized plants per crop cycle. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories.


The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the company has installations in multiple countries worldwide.


James M. Durward, President and CEO, stated: "MedXtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, MedXtractor offers significant potential upside for the cannabis investor."


For more information, please visit the company's website www.MEDXtractor.com, contact James M. Durward, President and CEO, at 403-689-3901 or by email at jimd@MEDXtractor.com.


About InvestmentPitch Media


InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community.


The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors. For more information please watch this video.


CONTACT:


InvestmentPitch Media


Barry Morgan, CFO


bmorgan@investmentpitch.com



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49131

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release MedXtractor Corp. Announces Listing on the CSE in MEDXTRACTOR CORP.

Calgary, Alberta--(Newsfile Corp. - October 23, 2019) - MedXtractor Corp. (CSE: MXT) ("MedX" or the "Corporation") is pleased to announce it has received a receipt from the Alberta Securities Commission for the filing of its final non-offering long form prospectus on October 9, 2019. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). All required listing documents have been filed with the Canadian Securities Exchange ("CSE") and the common shares of the Corporation are expected to commence trading on the CSE under the trading symbol "MXT" on October 24, 2019.


On October 9, 2019, the Corporation granted an aggregate of 375,000 stock options to a director of the Corporation exercisable on or before October 9, 2024, at an exercise price of $0.08 per common share.


The following individuals comprise MedX's board of directors and management team: James M. Durward (President, CEO, Corporate Secretary and Director), G. Steven Price (Director), Dusan Kuzma (Director), Dwayne Vinck (Chief Financial Officer) and Neil A. Runions (Director).


James M. Durward, the Corporation's President and CEO, states "MedXtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, MedXtractor offers significant potential upside for the cannabis investor."


In addition, the Corporation announces the filing of its unaudited interim condensed financial statements and management discussion and analysis for the six month period ended August 31, 2019. The filings are available for review on SEDAR (www.sedar.com).


ABOUT MEDXTRACTOR CORP.:


The Corporation is a Calgary-based company that manufactures proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the patents on its CO2-based extraction process.


FOR FURTHER INFORMATION, PLEASE CONTACT:


MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com


This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.


The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49065

!
Thumb jim photo

Jim Durward posted an update in MEDXTRACTOR CORP.

1 month ago

MEDXTRACTOR CORP. ANNOUNCES LISTING ON THE CSE

For Immediate Release

Calgary, Alberta – October 23, 2019. MedXtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) is pleased to announce it has received a receipt from the Alberta Securities Commission for the filing of its final non-offering long form prospectus on October 9, 2019. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). All required listing documents have been filed with the Canadian Securities Exchange (“CSE”) and the common shares of the Corporation are expected to commence trading on the CSE under the trading symbol “MXT” on October 24, 2019.

On October 9, 2019, the Corporation granted an aggregate of 375,000 stock options to a director of the Corporation exercisable on or before October 9, 2024 at an exercise price of $0.08 per common share.

The following individuals comprise Medx’s board of directors and management team: James M. Durward (President, CEO, Corporate Secretary and Director), G. Steven Price (Director), Dusan Kuzma (Director), Dwayne Vinck (Chief Financial Officer) and Neil A. Runions (Director).

James M. Durward, the Corporation’s President and CEO, states "Medxtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, Medxtractor offers significant potential upside for the cannabis investor.”

In addition, the Corporation announces the filing of its unaudited interim condensed financial statements and management discussion and analysis for the six month period ended August 31, 2019. The filings are available for review on SEDAR (www.sedar.com).

ABOUT MEDXTRACTOR CORP.:

The Corporation is a Calgary-based company that manufactures proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the patents on its CO2-based extraction process.

FOR FURTHER INFORMATION, PLEASE CONTACT:

MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Thumb d arcy pif photo 002

DArcy Funfer commented on Jim Durward  update in MEDXTRACTOR CORP.

2 months ago

October 10, 2019

Dear Fellow shareholders:

Today Medxtractor received its Alberta Securities Commission receipt for its prospectus. The Company has also received conditional approval to trade on the CSE under the symbol "MXT". This has all happened in less than 45 days since filing - I've been involved with initial prospectus offerings for over 30 years and I can tell you that this was fast. The transfer agent will mail your shares next week and management will coordinate a trading date with the CSE after all securities have been delivered - I expect sometime around the end of October. Unfortunately, the public-company cannabis "space" is in turmoil right now due primarily, in my opinion, to extreme overvaluations that could not be sustained in the face of lower-than-expected cannabis sales. The good news is that we are experiencing increasing sales and, due to continued tight capital controls, our cash reserves are growing - this is not something that many cannabis-related companies can rightfully claim. However, while operations are positive, I expect we will come to trade in a generally negative-sentiment period and I urge you to be patient and let the market settle down before making any buy-sell decisions.

Now that Medxtractor is a public company, I will not be able to communicate in the informal manner I have to date. I plan to send you News Releases and/or you can go to our SEDAR profile at
https://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045107. Thank you all for your support, and

Best Regards,

Jim
(403) 689-3901
jimd@medxtractor.com

https://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045107

Thumb 0

klacour

2 months ago

!

MedXtractor Corp.

publicPublic Group

MedXtractor manufactures patented, small-scale CO2-based cannabis oil extractors for sale worldwide We focus on hundreds-of-thousands of Craft-style growers who produce small-batch, very-high-quality cannabis products.

people23 Members       (0)

Corporate Profile
Group Admins:
  • Thumb d arcy pif photo 002
  • Thumb 8020 monitor 200200 2
  • Thumb 8020 media relations
  • Thumb no photo
Add Corporate Feed


MedXtractor Corp.

publicPublicGroup

MedXtractor manufactures patented, small-scale CO2-based cannabis oil extractors for sale worldwide We focus on hundr......

people23 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

5 hours ago

8020 Admin posted a press release MedXtractor Corp. Reports Increased Co2 Extractor Sales in MEDXTRACTOR CORP.

Calgary, Alberta--(Newsfile Corp. - December 4, 2019) - MedXtractor Corp. (CSE: MXT) ("MXT" or the "Corporation") announces an strong increase in extractor unit sales.


Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6610/50322_24075386948c59c0_002full.jpg


Figure 1


To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6610/50322_24075386948c59c0_002full.jpg


Mr. Jim Durward, CEO, states "While our unit sales have been trending upward over the past year, we believe that the Q3, 2020 jump is primarily due to seasonal harvest demand and that the trend may normalize in Q4. This said, the combination of US-Federal Hemp/CBD legalization, medical demand for extract purity due to the vape diluent issue and general demand for small-scale CO2-based extractors from the craft medical horizontal, is expected to support increasing organic growth going forward. With greater than 70% of sales now originating internationally, our growth prospects are worldwide and independent of the Canadian market. We focus on the craft medical horizontal, a generally overlooked market sector that we believe consists of a much larger number of potential customers than the far narrower corporate grower/extractor sector. For example, Health Canada reports that there were greater than 28,000 personal production licenses (June, 2019) vs. less than 300 large Licensed Producers. These craft growers are also not restricted as to the potency of their extracts and can use full-strength extracts without the addition of any diluents. MXT is uniquely positioned to support this horizontal with its affordable, small-scale CO2 extractors designed specifically for craft growers. While the capital markets have recently tightened for cannabis-related companies, our tight expense control means we don't require financing to execute our current business plan. I believe that our organic growth, combined with one of the lowest market capitalizations of any public cannabis-related company, makes MXT an excellent addition to any cannabis-related portfolio."


ABOUT MEDXTRACTOR CORP.:


The Corporation is a Calgary-based company that manufactures patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft medical cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the US patent, and the Canadian Patent application, on its CO2-based extraction process.


FOR FURTHER INFORMATION, PLEASE CONTACT:


MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com
Website: www.medxtractor.com


This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.


The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/50322

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release CSE New Listing - MEDXtractor Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com in MEDXTRACTOR CORP.

Vancouver, British Columbia--(Newsfile Corp. - October 25, 2019) -  MEDXtractor Corp. (CSE:MXT) is one of the latest new listings on the Canadian Securities Exchange. The Calgary-based company manufactures patented, proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials.




Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_ioncbvux/New-Listing-MEDXtractor-Corp-CSEMXT-


For more information, please view the InvestmentPitch Media "video" which provides additional information on the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "MEDXtractor" in the search box.


The company specifically targets the "Craft" cannabis grower. Craft growers are those whose crop is up to 800 indoor-sized plants per crop cycle. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories.


The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the company has installations in multiple countries worldwide.


James M. Durward, President and CEO, stated: "MedXtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, MedXtractor offers significant potential upside for the cannabis investor."


For more information, please visit the company's website www.MEDXtractor.com, contact James M. Durward, President and CEO, at 403-689-3901 or by email at jimd@MEDXtractor.com.


About InvestmentPitch Media


InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community.


The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors. For more information please watch this video.


CONTACT:


InvestmentPitch Media


Barry Morgan, CFO


bmorgan@investmentpitch.com



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49131

!
Thumb 8020 monitor 200200 2

8020 Admin

1 month ago

8020 Admin posted a press release MedXtractor Corp. Announces Listing on the CSE in MEDXTRACTOR CORP.

Calgary, Alberta--(Newsfile Corp. - October 23, 2019) - MedXtractor Corp. (CSE: MXT) ("MedX" or the "Corporation") is pleased to announce it has received a receipt from the Alberta Securities Commission for the filing of its final non-offering long form prospectus on October 9, 2019. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). All required listing documents have been filed with the Canadian Securities Exchange ("CSE") and the common shares of the Corporation are expected to commence trading on the CSE under the trading symbol "MXT" on October 24, 2019.


On October 9, 2019, the Corporation granted an aggregate of 375,000 stock options to a director of the Corporation exercisable on or before October 9, 2024, at an exercise price of $0.08 per common share.


The following individuals comprise MedX's board of directors and management team: James M. Durward (President, CEO, Corporate Secretary and Director), G. Steven Price (Director), Dusan Kuzma (Director), Dwayne Vinck (Chief Financial Officer) and Neil A. Runions (Director).


James M. Durward, the Corporation's President and CEO, states "MedXtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, MedXtractor offers significant potential upside for the cannabis investor."


In addition, the Corporation announces the filing of its unaudited interim condensed financial statements and management discussion and analysis for the six month period ended August 31, 2019. The filings are available for review on SEDAR (www.sedar.com).


ABOUT MEDXTRACTOR CORP.:


The Corporation is a Calgary-based company that manufactures proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the patents on its CO2-based extraction process.


FOR FURTHER INFORMATION, PLEASE CONTACT:


MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com


This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.


The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.



To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49065

!
Thumb jim photo

Jim Durward posted an update in MEDXTRACTOR CORP.

1 month ago

MEDXTRACTOR CORP. ANNOUNCES LISTING ON THE CSE

For Immediate Release

Calgary, Alberta – October 23, 2019. MedXtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) is pleased to announce it has received a receipt from the Alberta Securities Commission for the filing of its final non-offering long form prospectus on October 9, 2019. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). All required listing documents have been filed with the Canadian Securities Exchange (“CSE”) and the common shares of the Corporation are expected to commence trading on the CSE under the trading symbol “MXT” on October 24, 2019.

On October 9, 2019, the Corporation granted an aggregate of 375,000 stock options to a director of the Corporation exercisable on or before October 9, 2024 at an exercise price of $0.08 per common share.

The following individuals comprise Medx’s board of directors and management team: James M. Durward (President, CEO, Corporate Secretary and Director), G. Steven Price (Director), Dusan Kuzma (Director), Dwayne Vinck (Chief Financial Officer) and Neil A. Runions (Director).

James M. Durward, the Corporation’s President and CEO, states "Medxtractor is experiencing significant sales growth and, unlike most cannabis-related operations, is currently generating positive cash flow from operations. When combined with a market capitalization far below its peers, Medxtractor offers significant potential upside for the cannabis investor.”

In addition, the Corporation announces the filing of its unaudited interim condensed financial statements and management discussion and analysis for the six month period ended August 31, 2019. The filings are available for review on SEDAR (www.sedar.com).

ABOUT MEDXTRACTOR CORP.:

The Corporation is a Calgary-based company that manufactures proprietary craft-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. Growing demand is from the premium craft cannabis market as these growers respond to the shift toward high-purity oils and concentrates as the base for a multitude of products such as vapes, dabs, edibles, lotions, sprays, and suppositories. The ongoing worldwide cannabis legalization movement is expected to further increase demand for extracts and the Corporation has installations in multiple countries worldwide. The Corporation owns the patents on its CO2-based extraction process.

FOR FURTHER INFORMATION, PLEASE CONTACT:

MEDXTRACTOR CORP.
James M. Durward, President and CEO
Telephone: (403) 689-3901
Email: jimd@medxtractor.com

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Thumb d arcy pif photo 002

DArcy Funfer commented on Jim Durward  update in MEDXTRACTOR CORP.

2 months ago

October 10, 2019

Dear Fellow shareholders:

Today Medxtractor received its Alberta Securities Commission receipt for its prospectus. The Company has also received conditional approval to trade on the CSE under the symbol "MXT". This has all happened in less than 45 days since filing - I've been involved with initial prospectus offerings for over 30 years and I can tell you that this was fast. The transfer agent will mail your shares next week and management will coordinate a trading date with the CSE after all securities have been delivered - I expect sometime around the end of October. Unfortunately, the public-company cannabis "space" is in turmoil right now due primarily, in my opinion, to extreme overvaluations that could not be sustained in the face of lower-than-expected cannabis sales. The good news is that we are experiencing increasing sales and, due to continued tight capital controls, our cash reserves are growing - this is not something that many cannabis-related companies can rightfully claim. However, while operations are positive, I expect we will come to trade in a generally negative-sentiment period and I urge you to be patient and let the market settle down before making any buy-sell decisions.

Now that Medxtractor is a public company, I will not be able to communicate in the informal manner I have to date. I plan to send you News Releases and/or you can go to our SEDAR profile at
https://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045107. Thank you all for your support, and

Best Regards,

Jim
(403) 689-3901
jimd@medxtractor.com

https://sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045107

Thumb 0

klacour

2 months ago

!